文献速递生殖医学

接受生育治疗或尝试自然受孕患者中女性肥胖标志物与活产之间的关联

Association between markers of female adiposity and live birth among patients undergoing fertility treatment or attempting unassisted conception.
PubMed 文献 · Hum Reprod · 2025-01-01

本研究为FAZST试验的二次分析,纳入2370对寻求不育治疗的异性夫妇,随访9个月,评估BMI、体脂百分比、瘦素、脂联素/瘦素比值和腰围五种肥胖标志物与活产的关联。高BMI与活产概率降低相关(aRR 0.85,95%CI 0.74-0.98),体脂百分比显示出更强的关联(aRR 0.34,95%CI 0.22-0.55)。

要点

  • 高BMI与活产概率降低相关(aRR 0.85,95%CI 0.74-0.98)。
  • 体脂百分比与活产的关联更强(aRR 0.34,95%CI 0.22-0.55)。
  • 体脂百分比仅在部分参与者中可用,限制其推广性。

核心结论

  • 高肥胖与活产概率降低相关,大多数肥胖标志物表现与BMI相似,但体脂百分比可能作为肥胖评估的替代指标,尤其在接受不育治疗的患者中。

研究设计与样本

  • FAZST试验的二次分析,数据收集于2013年至2017年,纳入2370对在美国四个生育中心寻求不育治疗的异性夫妇,随访9个月,若妊娠则额外随访最多9个月。

主要发现

  • 高BMI与活产概率降低相关(aRR 0.85,95%CI 0.74-0.98)。
  • 体脂百分比与活产的关联更强(aRR 0.34,95%CI 0.22-0.55)。
  • 按三分位分析,即使中度升高的体脂百分比也与活产减少相关。
  • 按不育治疗状态分层后,大多数标志物的关联在接受不育治疗组中减弱,但体脂百分比仍与活产显著相关,然而该标志物仅在部分参与者中可用。

关键数值与推荐

  • 高肥胖定义采用文献中常用切点,通过五种标志物评估:BMI、双能X线吸收法(DXA)测量的体脂百分比、血清瘦素、血清脂联素/瘦素比值和腰围。
  • BMI数据可用率99.6%,体脂百分比7.3%(DXA仅在2016年至2017年间两个研究点对218名参与者提供),瘦素89.7%,脂联素/瘦素比值89.7%,腰围90.9%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅部分参与者接受DXA扫描并有体脂百分比数据,限制了该标志物与活产关联最强这一发现的普遍性。
  • 低BMI参与者很少,限制了对低肥胖如何影响生殖结局得出结论的能力。
  • 研究结果可能不适用于非不育人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Beyond BMI, are there better predictors of the impact of high female adiposity on reproductive outcomes in patients undergoing fertility treatment or attempting unassisted conception? SUMMARY ANSWER: Though BMI remains a predictor of fertility outcomes, alternative markers of adiposity, such as percent body fat, provide distinct information and may be more strongly associated with outcomes than BMI. WHAT IS KNOWN ALREADY: Elevated BMI is associated with a lower probability of live birth, though randomized trials have not consistently demonstrated the efficacy of weight loss for increasing live birth among patients utilizing infertility treatment. STUDY DESIGN, SIZE, DURATION: This was a secondary analysis of data gathered from 2013 to 2017 during the Folic Acid and Zinc Supplementation Trial (FAZST). Participants in FAZST included 2370 heterosexual couples seeking infertility care at four US fertility centers. Couples were followed for 9 months while undergoing fertility treatments or attempting unassisted conception, with up to 9 additional months of follow-up if pregnancy occurred. PARTICIPANTS/MATERIALS, SETTING, METHODS: For inclusion in the present study, female participants must have had at least one marker of adiposity measured at their baseline visit for FAZST. The primary exposure was high adiposity (defined by commonly used cutoffs in the literature) by each of five markers: BMI, percent body fat measured by dual-energy X-ray absorptiometry (DXA), serum leptin, serum adiponectin/leptin ratio, and waist circumference. Of the participants in FAZST, BMI was available for 99.6%, percent body fat for 7.3% (DXA only offered to 218 participants at two study sites between 2016 and 2017), leptin for 89.7%, adiponectin/leptin ratio for 89.7%, and waist circumference for 90.9%. Generalized linear models including age, race, parity, education, physical activity, male partner BMI ≥30 kg/m2, and Healthy Eating Index were used to estimate the relative risk of live birth. MAIN RESULTS AND THE ROLE OF CHANCE: High adiposity by BMI was associated with decreased probability of live birth (adjusted relative risk [aRR] 0.85, 95% CI 0.74-0.98). The other markers demonstrated similar associations, though a stronger effect size was seen with percent body fat (aRR 0.34, 95% CI 0.22-0.55). In an analysis by tertile, even moderately elevated percent body fat was associated with a decrease in live birth. When stratifying by infertility treatment status, associations were attenuated for most markers in the group utilizing infertility treatment, though percent body fat remained significantly associated with live birth. However, this marker was only available in a subset of participants. LIMITATIONS, REASONS FOR CAUTION: Only a subset of participants underwent DXA scans and had data on percent body fat, limiting the generalizability of the finding that this marker was most strongly associated with live birth. There were few participants with low BMIs, limiting the ability to draw conclusions on how low adiposity may affect reproductive outcomes. Findings may not be generalizable to the non-infertility population. WIDER IMPLICATIONS OF THE FINDINGS: The findings support prior data that high adiposity is associated with a lower probability of live birth. While most markers of adiposity performed similarly to BMI, there may be a role for percent body fat as an alternative assessment of adiposity, particularly among patients utilizing infertility treatment. STUDY FUNDING/COMPETING INTEREST(S): The FAZST and Impact of Diet, Exercise, and Lifestyle studies were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (contracts HHSN275201200007C, HHSN275201500001C, HHSN275201300026I/HHSN27500008, and HHSN275201300026I/HHSN27500018). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: NCT00467363 (secondary analysis).

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lee IT, Barnhart KT, Hwang WT, et al. Association between markers of female adiposity and live birth among patients undergoing fertility treatment or attempting unassisted conception. Hum Reprod. 2025. PMID: 40605077. doi:10.1093/humrep/deaf124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。